This Viewpoint reviews the development of immune checkpoint inhibitors as a new drug class for treating cancer, and discusses future directions including development of commercial assays for identifying response-to-treatment biomarkers and the use of combination regimens to improve response.
This Medical News story follows up on the recent downgrading of a form of thyroid cancer to a noncancerous neoplasm.
This study uses SEER database data to compare thyroid cancer incidence and mortality rates in the United States by cancer type and stage between 1974 and 2013.
This Medical News feature discusses the advances in clinical trial design and implementation that have grown out of the precision medicine approach.
This randomized clinical trial compares the effects of tailored dose-dense adjuvant chemotherapy vs standard adjuvant chemotherapy on recurrence-free survival in women with high-risk early breast cancer.
You currently have no searches saved.